These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3918304)

  • 1. Effects of two major activating lesions on the structure and conformation of human ras oncogene products.
    Srivastava SK; Yuasa Y; Reynolds SH; Aaronson SA
    Proc Natl Acad Sci U S A; 1985 Jan; 82(1):38-42. PubMed ID: 3918304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of ras GTP-binding mutants using an in situ colony-binding assay.
    Feig LA; Pan BT; Roberts TM; Cooper GM
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4607-11. PubMed ID: 3088563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of the ras gene product p21 that abolish guanine nucleotide binding.
    Clanton DJ; Hattori S; Shih TY
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5076-80. PubMed ID: 3014531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a human c-K-ras oncogene.
    Yamamoto F; Perucho M
    Nucleic Acids Res; 1984 Dec; 12(23):8873-85. PubMed ID: 6096811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function.
    Lacal JC; Aaronson SA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5400-4. PubMed ID: 2426696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular heterogeneity of the smg-21/Krev-1/rap1 proteins, a GTP-binding protein having the same effector domain as ras p21s, in bovine aortic smooth muscle membranes.
    Kawata M; Kawahara Y; Sunako M; Araki S; Koide M; Tsuda T; Fukuzaki H; Takai Y
    Oncogene; 1991 May; 6(5):841-8. PubMed ID: 1646988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophosphorylation of v-Ha-ras p21 is modulated by amino acid residue 12.
    Gibbs JB; Ellis RW; Scolnick EM
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2674-8. PubMed ID: 6609366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational alterations detected by circular dichroism induced in the normal ras p21 protein by activating point mutations at position 12, 59, or 61.
    Valencia A; Serrano L; Caballero R; Anderson PS; Lacal JC
    Eur J Biochem; 1988 Jul; 174(4):621-7. PubMed ID: 3292238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibody R256, specific for activated ras p21 with arginine at 12, and analysis of breast carcinoma of v-Harvey-ras transgenic mouse.
    Pullano TG; Sinn E; Carney WP
    Oncogene; 1989 Aug; 4(8):1003-8. PubMed ID: 2474786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of p21 ras proteins.
    Shih TY; Hattori S; Clanton DJ; Ulsh LS; Chen ZQ; Lautenberger JA; Papas TS
    Gene Amplif Anal; 1986; 4():53-72. PubMed ID: 3333361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of GTPases and GTPase regulatory proteins in oncogenesis.
    Grunicke HH; Maly K
    Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
    Chen JM; Brandt-Rauf PW; Pincus MR
    J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of monoclonal antibodies specific for ras p21 Glu-12 oncoproteins: detection in carcinogen-induced mammary carcinomas.
    Garlick DS; Sukumar S; Barbacid M; Petit D; Hamer PJ; Leav I; Lavecchio JA; Trimpe KL; Carney WP
    Hybridoma; 1991 Feb; 10(1):95-102. PubMed ID: 2032737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A monoclonal antibody reactive with an activated ras protein expressing valine at position 12.
    Carney WP; Hamer P; Petit D; Wolfe H; Cooper G; Lefebvre M; Rabin H
    J Cell Biochem; 1986; 32(3):207-14. PubMed ID: 3536974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p21 ras oncoproteins in human cancers.
    Tanaka T; Slamon DJ; Battifora H; Cline MJ
    Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences between a ras oncogene protein and the normal protein.
    Tong LA; de Vos AM; Milburn MV; Jancarik J; Noguchi S; Nishimura S; Miura K; Ohtsuka E; Kim SH
    Nature; 1989 Jan; 337(6202):90-3. PubMed ID: 2642607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of activated Mr 21,000 protein, the product of ras oncogenes, using antibodies with specificity for amino acid 12.
    Wong G; Arnheim N; Clark R; McCabe P; Innis M; Aldwin L; Nitecki D; McCormick F
    Cancer Res; 1986 Dec; 46(12 Pt 1):6029-33. PubMed ID: 3490906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody specific for an activated RAS protein.
    Carney WP; Petit D; Hamer P; Der CJ; Finkel T; Cooper GM; Lefebvre M; Mobtaker H; Delellis R; Tischler AS
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7485-9. PubMed ID: 3094010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.